drugset
Drugs / Puumala virus vaccine (PUUV)
last change Oct 2022 re-read 3 minutes ago

Puumala virus vaccine (PUUV)

Vaccine

Developed for
hantavirus infectious disease
Investigated by
Ichor Medical Systems Incorporated · National Institute of Allergy and Infectious Diseases (NIAID) · The Geneva Foundation · U.S. Army Medical Research and Development Command · US Army Medical Research Institute of Infectious Diseases

Trials 1

today NCT03718130 · Ph 1
2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT03718130 Jul 2019 → Oct 2022 hantavirus infectious disease U.S. Army Medical Research and Development Command Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Puumala virus vaccine (PUUV) ClinicalTrials.gov intervention name — accepted as the source's own label NCT03718130 ↗
Modality Vaccine “hantaan virus (HTNV), puumala virus (PUUV), and combination HTNV/PUUV DNA vaccine candidates” NCT03718130 ↗